Search press releases
Every release here is real and links to its original. Filter by company, topic, language and date.
- Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
- GoogleStudy in The Lancet suggests AI could improve patient-physician relationships.Companies: Alphabet Inc.A peer-reviewed study in The Lancet evaluates Google's AMIE medical AI in a real-world primary care clinic.
- Psyched Wellness Ltd.Psyched Wellness Announces Secured Term LoanPsyched Wellness Ltd. (CSE: PSYC) (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. (together the "Lenders") for an aggregate principal amount of US$110,577 (the "Loan")....
- Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMSClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased or otherwise acquired the Company’s securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
- Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax®-L ProductionNorthwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, and the UK National Health Service Blood and Transplant ("NHSBT") announce that...
- Rare BeautySELENA GOMEZ ANNOUNCES LEON BRIDGES AND BELLA KAY AS ENTERTAINMENT FOR THE FOURTH ANNUAL RARE IMPACT FUND BENEFITThe Rare Impact Fund Benefit: A Night of Radiance & Reflection, which will support youth mental health organizations, will take place on October 14 in Los Angeles — The Rare Impact Fund today announced the special musical guests set to take the...
- Guardant Health, Inc.Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast CancerCompanies: AstraZenecaPALO ALTO, Calif., October 08, 2026--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Guardant360® CDx has received CE-marking under Europe’s in Vitro Diagnostic Medical Devices Regulation as a companion diagnostic (CDx) to identify patients with estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer who may benefit from treatment with ETCAMAH™ (camizestrant), AstraZeneca’s next-generation oral selective estrogen
- Guardant Health, Inc.Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026PALO ALTO, Calif., October 08, 2026--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2026 after market close on Thursday, November 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m.
- Sophos IRB, Inc.ALCMI and Sophos IRB Form Strategic Partnership to Advance Lung Cancer Clinical ResearchPartnership pairs ALCMI's international lung cancer research network with Sophos IRB's specialized oncology IRB expertise. — The Addario Lung Cancer Medical Institute (ALCMI), an international nonprofit specializing in investigator-initiated...
- APLA HealthMICHAELA JAÉ RODRIGUEZ TO BE HONORED BY APLA HEALTH AT THE 42ND ANNUAL AIDS WALK LOS ANGELES ON OCTOBER 18, 2026Joel Kim Booster to present Rodriguez with the Voice of Visibility Award, followed by an Opening Ceremony Performance from Singer/Songwriter David Archuleta — APLA Health announced today it will present its inaugural Voice of Visibility Award to...
- Basel Medical Group Ltd (BMGL) Prices Registered Direct OfferingBasel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today entered into a placement agency agreement with Cathay Securities, Inc., as the placement agent (the “Placement Agent”), as well as a securities purchase agreement with certain purchasers, pursuant to which the Company will issue and sell 6,000,000 units (the “Units”), at a public offering price of US$1.33 per Unit, each consisting of one ordinary share with no par value (each an “Ordinary Share” and collectively the “Ordinary Shares”) or one Pre-Funded Warrant (defined below) of the Company, and one warrant (“Common Warrant”), each to purchase one Ordinary Share.
- The American Academy of OtolaryngologyFrom Gene Therapy to Whole-Body Health: Major ENT Research Coming to Los AngelesMore than 5,000 ear, nose and throat specialists from around the world will gather in Los Angeles next week for the American Academy of Otolaryngology–Head and Neck Surgery's 2026 Annual Meeting & OTO EXPO. The event will feature new research on...